Serina Therapeutics Stock Market Value
| SER Stock | 4.79 0.64 15.42% |
| Symbol | Serina |
Serina Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Serina Therapeutics. If investors know Serina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Serina Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.568 | Earnings Share 0.14 | Revenue Per Share 0.787 | Quarterly Revenue Growth 6.286 | Return On Assets (0.45) |
The market value of Serina Therapeutics is measured differently than its book value, which is the value of Serina that is recorded on the company's balance sheet. Investors also form their own opinion of Serina Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Serina Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Serina Therapeutics' market value can be influenced by many factors that don't directly affect Serina Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Serina Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Serina Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Serina Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Serina Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Serina Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Serina Therapeutics.
| 11/18/2024 |
| 12/18/2024 |
If you would invest 0.00 in Serina Therapeutics on November 18, 2024 and sell it all today you would earn a total of 0.00 from holding Serina Therapeutics or generate 0.0% return on investment in Serina Therapeutics over 30 days. Serina Therapeutics is related to or competes with Lipocine, Waste Management, Artisan Partners, SEI Investments, Minerals Technologies, Nuvalent, and NETGEAR. Serina Therapeutics is entity of United States More
Serina Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Serina Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Serina Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 44.89 | |||
| Value At Risk | (9.81) | |||
| Potential Upside | 15.42 |
Serina Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Serina Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Serina Therapeutics' standard deviation. In reality, there are many statistical measures that can use Serina Therapeutics historical prices to predict the future Serina Therapeutics' volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | 0.1787 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Serina Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Serina Therapeutics Backtested Returns
Serina Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.007, which indicates the firm had a -0.007% return per unit of risk over the last 3 months. Serina Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Serina Therapeutics' Variance of 60.13, coefficient of variation of (5,360), and insignificant Risk Adjusted Performance to confirm the risk estimate we provide. The entity has a beta of -0.87, which indicates possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Serina Therapeutics are expected to decrease slowly. On the other hand, during market turmoil, Serina Therapeutics is expected to outperform it slightly. At this point, Serina Therapeutics has a negative expected return of -0.0552%. Please make sure to validate Serina Therapeutics' treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Serina Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.19 |
Very weak predictability
Serina Therapeutics has very weak predictability. Overlapping area represents the amount of predictability between Serina Therapeutics time series from 18th of November 2024 to 3rd of December 2024 and 3rd of December 2024 to 18th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Serina Therapeutics price movement. The serial correlation of 0.19 indicates that over 19.0% of current Serina Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.19 | |
| Spearman Rank Test | -0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 0.28 |
Serina Therapeutics lagged returns against current returns
Autocorrelation, which is Serina Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Serina Therapeutics' stock expected returns. We can calculate the autocorrelation of Serina Therapeutics returns to help us make a trade decision. For example, suppose you find that Serina Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Serina Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Serina Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Serina Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Serina Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Serina Therapeutics Lagged Returns
When evaluating Serina Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Serina Therapeutics stock have on its future price. Serina Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Serina Therapeutics autocorrelation shows the relationship between Serina Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Serina Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Serina Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Serina Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Serina Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Serina Stock
Moving against Serina Stock
| 0.73 | GILD | Gilead Sciences | PairCorr |
| 0.71 | BMY | Bristol Myers Squibb | PairCorr |
| 0.62 | DYAI | Dyadic International | PairCorr |
| 0.53 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
The ability to find closely correlated positions to Serina Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Serina Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Serina Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Serina Therapeutics to buy it.
The correlation of Serina Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Serina Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Serina Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Serina Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Serina Stock Analysis
When running Serina Therapeutics' price analysis, check to measure Serina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Serina Therapeutics is operating at the current time. Most of Serina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Serina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Serina Therapeutics' price. Additionally, you may evaluate how the addition of Serina Therapeutics to your portfolios can decrease your overall portfolio volatility.